GTPBP1 Knockout Jurkat Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population of the human Jurkat T lymphocyte cell line, designed for loss-of-function studies of the GTPBP1 gene. This gene-edited cell product provides a robust model for investigating GTPBP1-dependent translational control and stress response pathways. The polyclonal knockout format reflects a heterogeneous pool of cells with target-gene disruption introduced by CRISPR/Cas9, avoiding clonal selection artifacts.
The Jurkat cell line is an immortalized human T lymphocyte line originally derived from an acute T cell leukemia patient. These cells are widely used as a model for T cell signaling, activation, and apoptosis, as well as for studying acute lymphoblastic leukemia biology. Jurkat cells exhibit constitutive activation of T cell receptor signaling pathways and provide a well-characterized platform for genetic manipulation and mechanistic dissection of immune cell function.
GTPBP1 encodes a GTPase that localizes to ribosomes and stress granules, where it plays a critical role in translational regulation during cellular stress. It is activated downstream of eIF2?? kinases such as PERK, PKR, and GCN2, which phosphorylate eIF2?? in response to oxidative stress and heat shock, triggering the integrated stress response. GTPBP1 interacts with stress granule components including G3BP1, TIA-1, and PABPC1, and modulates ribosome-associated quality control. It functions within the mTORC1 signaling axis and influences downstream effectors like ATF4 and CHOP, thereby linking translational arrest to stress granule dynamics and mRNA surveillance.
In Jurkat T cells, GTPBP1 knockout provides a valuable tool for dissecting how stress granule assembly and translational reprogramming contribute to T cell activation, survival under oxidative stress, and leukemogenesis. The disruption of GTPBP1 may alter the adaptive response to endoplasmic reticulum stress and nutrient deprivation, processes known to impact T cell function and leukemia cell viability. This model is particularly relevant for studying the intersection of mTOR signaling, eIF2?? phosphorylation, and stress granule formation in the context of immune cell biology and malignancy.
Typical applications include investigating translational control mechanisms in T cells, characterizing stress granule dynamics in leukemia, and evaluating the integrated stress response in immune cell stress adaptation. Researchers can employ assays such as immunofluorescence for stress granule markers (G3BP1, TIA-1), polysome profiling, eIF2?? phosphorylation analysis, Western blotting, RT-qPCR, flow cytometry for apoptosis, and co-immunoprecipitation of interacting proteins. RNA-seq can be used to assess transcriptome-wide changes upon stress. For further details or to discuss specific experimental needs, please contact Ascent Research.
